Pre-Session Views
Update: 2025-11-25
Description
In today's views
- Strategy | Reiterating small-cap pharma call: Nile Pharma bubble crashed and Memphis Pharma will likely outperform in 2026
- MFPC roundtable takeaways | Structural export advantage reinforced, limited CBAM risk, and clear investment path ahead
- CICH | 9M25 resilience underscores our EGP13/share fair value
- TWSA | Preliminary indicators show promising growth in factoring
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
